SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

11276	Companies
250579	Keywords
179215	Articles
136417	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 10/17/2025 at 13:00, 1 year ago

Communiqué de presse : Sanofi fournit une mise à jour de l’examen réglementaire du Rezurock dans l’UE pour le traitement de la maladie chronique du greffon contre l’hôte
Sanofi demande un réexamen après un avis négatif du CHMP pour le Rezurock dans le traitement de la maladie chronique du greffon contre l’hôte en Europe

Sanofi CHMP Rezurock Maladie Chronique Greffon
BRIEF

published on 10/08/2025 at 07:05, 1 year ago

AlphaMedixTM : des résultats positifs en phase 2 pour le traitement des TNE-GEP

Essai Clinique Phase 2 Thérapie Innovante AlphaMedixTM TNE-GEP
BRIEF

published on 10/08/2025 at 07:05, 1 year ago

AlphaMedixTM: Positive Phase 2 Results for the Treatment of GEP-NETs

Clinical Trial Phase 2 Innovative Therapy AlphaMedixTM TNE-GEP
PRESS RELEASE

published on 10/08/2025 at 07:00, 1 year ago

Communiqué de presse : AlphaMedixTM (212Pb-DOTAMTATE) a satisfait l’ensemble des critères d’évaluation principaux d’efficacité lors de l’essai de phase 2, démontrant des bénéfices cliniquement significatifs chez les patients atteints
AlphaMedixTM (212Pb-DOTAMTATE) satisfait les critères d'évaluation principaux d'efficacité dans l'essai de phase 2 pour les tumeurs neuroendocrines gastro-entéro-pancréatiques. Résultats prometteurs d'alphathérapie ciblée au plomb-212

Essai De Phase 2 Tumeurs Neuroendocrines AlphaMedixTM 212Pb-DOTAMTATE Alphathérapie Ciblée
BRIEF

published on 09/24/2025 at 07:10, 1 year 1 month ago

Sanofi investit 625 millions de dollars pour booster Sanofi Ventures

Investissement Innovation Santé Numérique Sanofi Biotechnologies
BRIEF

published on 09/24/2025 at 07:10, 1 year 1 month ago

Sanofi invests $625 million to boost Sanofi Ventures

Innovation Digital Health Investment Sanofi Biotechnologies
BRIEF

published on 09/24/2025 at 07:05, 1 year 1 month ago

Sanofi Releases Q3 2025 Aide Mémoire

Investor Relations Sanofi Financial Modeling Results Announcement Q3 2025
BRIEF

published on 09/24/2025 at 07:05, 1 year 1 month ago

Sanofi publie son aide-mémoire pour le troisième trimestre 2025

Relations Avec Les Investisseurs Sanofi Annonce Des Résultats Modélisation Financière T3 2025
PRESS RELEASE

published on 09/24/2025 at 07:05, 1 year 1 month ago

Communiqué de presse : Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique
Sanofi investit 625 millions de dollars supplémentaires dans Sanofi Ventures pour accélérer les investissements en biotechnologies et innovation numérique dans la santé

Investissement Innovation Santé Numérique Sanofi Biotechnologies
PRESS RELEASE

published on 09/24/2025 at 07:05, 1 year 1 month ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits $625 million to Sanofi Ventures to boost biotech and digital health investments. Focus on immunology, rare diseases, neurology, vaccines

Digital Health Investment Biotech Ventures Sanofi

Accesswire

Published on 11/04/2026 at 23:10, 1 hour 19 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 1 hour 29 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 1 hour 29 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 2 hours 14 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 2 hours 24 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 00:02, 26 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 4 hours 48 minutes ago

EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 5 hours 4 minutes ago

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 5 hours 46 minutes ago

EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 6 hours 24 minutes ago

Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production

Les Echos

Published on 11/04/2026 at 18:00, 6 hours 29 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 6 hours 29 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 6 hours 44 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 6 hours 44 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 6 hours 45 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE